Infectious Disease Testing/Diagnostic Market - Forecast(2021 - 2026)

Report Code: HCR 0085 Report Format: PDF + Excel (Delivery in 48 Hrs)

Infectious Disease Testing Market Overview

The Infectious Disease Testing Market size is forecast to reach $23.45 billion by 2025, growing at a CAGR of 5.8% during the forecast period 2020-2025. Infectious disease is caused by bacteria, viruses, and others and has a huge impact on the Healthcare systems of the countries. Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases. Infectious diseases testing samples include blood, urine, and other bodily fluids. Growing demand for rapid diagnostic techniques over the current techniques owing to the long turnaround time and supportive government funding along with the growing awareness for early detection using specific Diagnostic tests is the major factor driving the growth of the market. The shift in focus from centralized laboratories to decentralized point-of-care testing services is set to further enhance the overall market demand for the Infectious Disease Testing Market during the forecast period 2020-2025.

Report Coverage

The report: “Infectious Disease Testing Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Infectious Disease Testing Market. 
By Product & Service: Consumables, Instruments, and Software & Service
By Disease Type: Hepatitis, Human Immunodeficiency Virus, Human Papilloma Virus Tuberculosis, Influenza, and Others
By Technology: Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, DNA Microarray Technology, Next Generation Sequencing, and Others
By End Users: Hospital/ Clinical Laboratories, Reference Laboratories, Academics & Research Institutes and Others
By Geography: North America, Europe, Asia Pacific, and Rest of the World (RoW)

Key Takeaways

  • North America dominated the Infectious Disease Testing Market in 2019 owing to the increasing investments by healthcare providers towards infrastructure, improvement and the need to manage the growing burden of infectious diseases. The Infectious Disease Testing Market scope for different regions will be provided in the final report.
  • Increasing epidemics of infectious diseases requires continuous testing and changing regulatory policies to mandate the infectious disease testing for the general population is likely to aid in the market growth of the Infectious Disease Testing Market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Infectious Disease Testing Market report.
  • Unfavourable and inadequate reimbursement scenario is poised to create hurdles for the Infectious Disease Testing Market.

Infectious Disease Testing Market Segment Analysis - By Disease Type

The Hepatitis segment held the largest share in the Infectious Disease Testing Market in 2019 and is estimated to grow at a CAGR of 6.11% during the forecast period 2020-2025 owing to the increasing number of blood transfusions and donations, increasing prevalence of hepatitis B & C infections, rising susceptibility of the geriatric population, growing awareness among the population, and benefits offered by point of care instruments & kits. Growth in the HAI segment can be attributed to the rising burden of MRSA infections, the increasing number of new products launched in the market, and increasing adoption of technologically advanced HAI diagnostic tests such as BD MAX Cdiff assay, Xpert MRSA NxG, and ARIES C. difficile Assay that are based on PCR technology. HPV infections can be prevented if diagnosed in the early stages. Pap tests are the most preferred tests to detect cervical cancer. Rapid HPV diagnostics and real-time PCR are the most advanced methods which have 95% sensitivity to HPV and cover a broad range of genotypes. Growth in the influenza market can be attributed to the rising prevalence of influenza, growth in research funding for influenza diagnostics, and rising demand for faster diagnosis and control of influenza. Hepatitis is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.

Infectious Disease Testing Market Segment Analysis - By End Users

The Hospitals & clinics segment held the largest share in the Infectious Disease Testing Market in 2019. Hospitals/clinical laboratories primarily serve to conduct tests on samples collected from the inpatient and outpatient population. These laboratories perform IDD tests to identify or diagnose diseases and determine relevant treatments. Most of these laboratories are equipped with fully automated diagnostic instruments such as NGS, PCR, and mass spectrometry for providing better medical diagnostic results to patients. Compared to reference laboratories, hospital laboratories are more accessible and offer test results quickly. Furthermore, these laboratories provide flexibility in terms of scheduling specimen pickups. Hospitals & Clinics are set to be the highest growing segment and are estimated to register the highest CAGR during the forecast period 2020-2025.

Infectious Disease Testing Market Segment Analysis - Geography

North America dominated the Infectious Disease Testing Market in 2019 with a share of more than 36.12%, followed by Europe owing to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage the growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases. Further, changing regulatory policies to mandate the infectious disease testing for the general population fueled the growth of the market. Along with these, technology has integrated the existing manual operations and led to the development of a fully automated process. Thus, increasing the growth of the Infectious Disease Testing Market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the growing presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.

Infectious Disease Testing Market Drivers

Growing awareness about personalized medicine

Growing awareness about personalized medicine is increasing the growth of the Infectious Disease Testing Market. Diagnostic tests can be used to assess the efficacy of specific therapeutic agents in particular patients. With the help of diagnostic tests, patients who suffer disproportionately severe adverse effects from a given treatment or dosage can be identified. Moreover, diagnostic tests help in determining the optimal dosages for drugs whose therapeutic effects are known to vary widely among different patient groups. The extent or progression of a disease and preventive measures can be identified in patients through diagnostic tests. With the growing demand for personalized medicine, the demand for such diagnostic tests is expected to increase globally. Growing patient awareness about the benefits of personalized medicine is one of the key factors resulting in the increased use of molecular diagnostics and genomics & proteomics technologies in infectious disease testing. Thus, increasing the growth of the Infectious Disease Testing Market during the forecast period 2020-2025.

Increasing global prevalence of infectious diseases

Increasing global prevalence of infectious disease is increasing the growth of the Infectious Disease Testing Market. The global prevalence of infectious diseases such as influenza, HPV, hepatitis, HIV, and tuberculosis is considerably high in spite of significant improvements in sanitation practices and medicine. Many of the currently available diagnostic techniques are slow, involve complex procedures, and lack specific identification of causative agents. Owing to this, patients receive empiric, broad-spectrum antimicrobial therapy rather than appropriate therapies. This has resulted in the emergence of super-resistant microbes. Thus, increasing the growth of the Infectious Disease Testing Market during the forecast period 2020-2025.

Infectious Disease Testing Market Challenges

Unfavorable and inadequate reimbursement scenario 

Some of the factors that are set to impede the growth of the Infectious Disease Testing Market are the unfavorable and inadequate reimbursement scenario.

Infectious Disease Testing Market Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Infectious Disease Testing Market. In 2019, the Infectious Disease Testing Market share is consolidated by the top ten players present in the market. Infectious Disease Testing Market, the top 10 companies are Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc., bioMérieux S.A., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, DiaSorin S.p.A., Meridian Bioscience Inc., and Quidel Corporation among others.

Acquisitions/Product Launches

  • In June 2018, F. Hoffmann-La Roche Ltd. entered into a strategic partnership with GE Healthcare to jointly develop and co-market digital clinical decision support solutions.
  • In May 2018, Qiagen and DiaSorin entered into a partnership to offer fully automated tuberculosis detection with QuantiFERON-TB Gold plus available on LIAISON analyzer system.

1. Infectious Disease Testing Market - Overview
    1.1 Definitions and Scope
2. Infectious Disease Testing Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product & Solution
    2.3 Key trends by End Users
    2.4 Key trends by Geography
3. Infectious Disease Testing Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Infectious Disease Testing Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Infectious Disease Testing Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Infectious Disease Testing Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Infectious Disease Testing Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Infectious Disease Testing Market – By Product & Service(Market Size – $Million/$Billion)
    8.1 Consumables
    8.2 Instruments
    8.3 Software & Service
9. Infectious Disease Testing Market – By Disease Type(Market Size – $Million/$Billion)
    9.1 Hepatitis
    9.2 Human Immunodeficiency Virus
    9.3 Human Papillomavirus
    9.4 Tuberculosis
    9.5 Influenza
    9.6 Others
10. Infectious Disease Testing Market  – By Technology(Market Size – $Million/$Billion)
    10.1 Immunodiagnostics
    10.2 Clinical Microbiology
    10.3 Polymerase Chain Reaction
    10.4 DNA Microarray Technology
    10.5 Next Generation Sequencing
    10.6 Others
11. Infectious Disease Testing Market – By End Users(Market Size –$Million/$Billion)
    11.1 Hospital/Clinical Laboratories
    11.2 Reference Laboratories
    11.3 Academics & Research Institutes
    11.4 Others
12. Infectious Disease Testing Market - By Geography(Market Size –$Million/$Billion) 
    12.1 North America
        12.1.1 U.S.
        12.1.2 Mexico
        12.1.3 Canada
    12.2 Europe
        12.2.1 U.K.
        12.2.2 France
        12.2.3 Germany
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of APAC
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Infectious Disease Testing Market - Entropy
14. Infectious Disease Testing Market – Industry/Segment Competition Landscape Premium 
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Best Practices for Companies
15. Infectious Disease Testing Market – Key Company List by Country Premium Premium
16. Infectious Disease Testing Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: Infectious Disease Testing Market Overview 2021-2026
Table 2: Infectious Disease Testing Market Leader Analysis 2018-2019 (US$)
Table 3: Infectious Disease Testing Market Product Analysis 2018-2019 (US$)
Table 4: Infectious Disease Testing Market End User Analysis 2018-2019 (US$)
Table 5: Infectious Disease Testing Market Patent Analysis 2013-2018* (US$)
Table 6: Infectious Disease Testing Market Financial Analysis 2018-2019 (US$)
Table 7: Infectious Disease Testing Market Driver Analysis 2018-2019 (US$)
Table 8: Infectious Disease Testing Market Challenges Analysis 2018-2019 (US$)
Table 9: Infectious Disease Testing Market Constraint Analysis 2018-2019 (US$)
Table 10: Infectious Disease Testing Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Infectious Disease Testing Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Infectious Disease Testing Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Infectious Disease Testing Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Infectious Disease Testing Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Infectious Disease Testing Market Value Chain Analysis 2018-2019 (US$)
Table 16: Infectious Disease Testing Market Pricing Analysis 2021-2026 (US$)
Table 17: Infectious Disease Testing Market Opportunities Analysis 2021-2026 (US$)
Table 18: Infectious Disease Testing Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Infectious Disease Testing Market Supplier Analysis 2018-2019 (US$)
Table 20: Infectious Disease Testing Market Distributor Analysis 2018-2019 (US$)
Table 21: Infectious Disease Testing Market Trend Analysis 2018-2019 (US$)
Table 22: Infectious Disease Testing Market Size 2018 (US$)
Table 23: Infectious Disease Testing Market Forecast Analysis 2021-2026 (US$)
Table 24: Infectious Disease Testing Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2021-2026 ($)
Table 26: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By Introduction, 2021-2026 ($)
Table 27: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By Influenza, 2021-2026 ($)
Table 28: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By Hepatitis, 2021-2026 ($)
Table 29: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By AIDS, 2021-2026 ($)
Table 30: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By Tuberculosis, 2021-2026 ($)
Table 31: Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2021-2026 ($)
Table 32: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Introduction, 2021-2026 ($)
Table 33: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Immuno diagnostics, 2021-2026 ($)
Table 34: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Biochemical Characterization, 2021-2026 ($)
Table 35: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Microscopy, 2021-2026 ($)
Table 36: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Polymerase Chain Reaction(PCR), 2021-2026 ($)
Table 37: Infectious Disease Testing Market, Revenue & Volume, By Industry, 2021-2026 ($)
Table 38: Infectious Disease Testing Market By Industry, Revenue & Volume, By Laboratories, 2021-2026 ($)
Table 39: Infectious Disease Testing Market By Industry, Revenue & Volume, By Nursing Homes, 2021-2026 ($)
Table 40: Infectious Disease Testing Market By Industry, Revenue & Volume, By Blood Banks, 2021-2026 ($)
Table 41: Infectious Disease Testing Market By Industry, Revenue & Volume, By Hospitals, 2021-2026 ($)
Table 42: Infectious Disease Testing Market By Industry, Revenue & Volume, By Research Labs, 2021-2026 ($)
Table 43: North America Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2021-2026 ($)
Table 44: North America Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2021-2026 ($)
Table 45: North America Infectious Disease Testing Market, Revenue & Volume, By Industry, 2021-2026 ($)
Table 46: South america Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2021-2026 ($)
Table 47: South america Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2021-2026 ($)
Table 48: South america Infectious Disease Testing Market, Revenue & Volume, By Industry, 2021-2026 ($)
Table 49: Europe Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2021-2026 ($)
Table 50: Europe Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2021-2026 ($)
Table 51: Europe Infectious Disease Testing Market, Revenue & Volume, By Industry, 2021-2026 ($)
Table 52: APAC Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2021-2026 ($)
Table 53: APAC Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2021-2026 ($)
Table 54: APAC Infectious Disease Testing Market, Revenue & Volume, By Industry, 2021-2026 ($)
Table 55: Middle East & Africa Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2021-2026 ($)
Table 56: Middle East & Africa Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2021-2026 ($)
Table 57: Middle East & Africa Infectious Disease Testing Market, Revenue & Volume, By Industry, 2021-2026 ($)
Table 58: Russia Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2021-2026 ($)
Table 59: Russia Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2021-2026 ($)
Table 60: Russia Infectious Disease Testing Market, Revenue & Volume, By Industry, 2021-2026 ($)
Table 61: Israel Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2021-2026 ($)
Table 62: Israel Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2021-2026 ($)
Table 63: Israel Infectious Disease Testing Market, Revenue & Volume, By Industry, 2021-2026 ($)
Table 64: Top Companies 2018 (US$) Infectious Disease Testing Market, Revenue & Volume
Table 65: Product Launch 2018-2019 Infectious Disease Testing Market, Revenue & Volume
Table 66: Mergers & Acquistions 2018-2019 Infectious Disease Testing Market, Revenue & Volume


List of Figures

Figure 1: Overview of Infectious Disease Testing Market 2021-2026
Figure 2: Market Share Analysis for Infectious Disease Testing Market 2018 (US$)
Figure 3: Product Comparison in Infectious Disease Testing Market 2018-2019 (US$)
Figure 4: End User Profile for Infectious Disease Testing Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Infectious Disease Testing Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Infectious Disease Testing Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Infectious Disease Testing Market 2018-2019
Figure 8: Ecosystem Analysis in Infectious Disease Testing Market 2018
Figure 9: Average Selling Price in Infectious Disease Testing Market 2021-2026
Figure 10: Top Opportunites in Infectious Disease Testing Market 2018-2019
Figure 11: Market Life Cycle Analysis in Infectious Disease Testing Market
Figure 12: GlobalBy Type Of Disease Infectious Disease Testing Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy Testing Technique Infectious Disease Testing Market Revenue, 2021-2026 ($)
Figure 14: GlobalBy Industry Infectious Disease Testing Market Revenue, 2021-2026 ($)
Figure 15: Global Infectious Disease Testing Market - By Geography
Figure 16: Global Infectious Disease Testing Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 17: Global Infectious Disease Testing Market CAGR, By Geography, 2021-2026 (%)
Figure 18: North America Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 19: US Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 20: US GDP and Population, 2018-2019 ($)
Figure 21: US GDP – Composition of 2018, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2018-2019 ($)
Figure 23: Canada Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 24: Canada GDP and Population, 2018-2019 ($)
Figure 25: Canada GDP – Composition of 2018, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 27: Mexico Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 28: Mexico GDP and Population, 2018-2019 ($)
Figure 29: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 31: South America Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 33: Brazil GDP and Population, 2018-2019 ($)
Figure 34: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 36: Venezuela Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 37: Venezuela GDP and Population, 2018-2019 ($)
Figure 38: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 40: Argentina Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 41: Argentina GDP and Population, 2018-2019 ($)
Figure 42: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 44: Ecuador Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 45: Ecuador GDP and Population, 2018-2019 ($)
Figure 46: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 48: Peru Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 49: Peru GDP and Population, 2018-2019 ($)
Figure 50: Peru GDP – Composition of 2018, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 52: Colombia Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 53: Colombia GDP and Population, 2018-2019 ($)
Figure 54: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 56: Costa Rica Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 57: Costa Rica GDP and Population, 2018-2019 ($)
Figure 58: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 60: Europe Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 61: U.K Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 62: U.K GDP and Population, 2018-2019 ($)
Figure 63: U.K GDP – Composition of 2018, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 65: Germany Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 66: Germany GDP and Population, 2018-2019 ($)
Figure 67: Germany GDP – Composition of 2018, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 69: Italy Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 70: Italy GDP and Population, 2018-2019 ($)
Figure 71: Italy GDP – Composition of 2018, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 73: France Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 74: France GDP and Population, 2018-2019 ($)
Figure 75: France GDP – Composition of 2018, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2018-2019 ($)
Figure 77: Netherlands Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 78: Netherlands GDP and Population, 2018-2019 ($)
Figure 79: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 81: Belgium Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 82: Belgium GDP and Population, 2018-2019 ($)
Figure 83: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 85: Spain Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 86: Spain GDP and Population, 2018-2019 ($)
Figure 87: Spain GDP – Composition of 2018, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 89: Denmark Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 90: Denmark GDP and Population, 2018-2019 ($)
Figure 91: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 93: APAC Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 94: China Infectious Disease Testing Market Value & Volume, 2021-2026
Figure 95: China GDP and Population, 2018-2019 ($)
Figure 96: China GDP – Composition of 2018, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2018-2019 ($) Infectious Disease Testing Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 98: Australia Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 99: Australia GDP and Population, 2018-2019 ($)
Figure 100: Australia GDP – Composition of 2018, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 102: South Korea Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 103: South Korea GDP and Population, 2018-2019 ($)
Figure 104: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 106: India Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 107: India GDP and Population, 2018-2019 ($)
Figure 108: India GDP – Composition of 2018, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2018-2019 ($)
Figure 110: Taiwan Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 111: Taiwan GDP and Population, 2018-2019 ($)
Figure 112: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 114: Malaysia Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 115: Malaysia GDP and Population, 2018-2019 ($)
Figure 116: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 118: Hong Kong Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 119: Hong Kong GDP and Population, 2018-2019 ($)
Figure 120: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 122: Middle East & Africa Infectious Disease Testing Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 123: Russia Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 124: Russia GDP and Population, 2018-2019 ($)
Figure 125: Russia GDP – Composition of 2018, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 127: Israel Infectious Disease Testing Market Value & Volume, 2021-2026 ($)
Figure 128: Israel GDP and Population, 2018-2019 ($)
Figure 129: Israel GDP – Composition of 2018, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 131: Entropy Share, By Strategies, 2018-2019* (%) Infectious Disease Testing Market
Figure 132: Developments, 2018-2019* Infectious Disease Testing Market
Figure 133: Company 1 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 134: Company 1 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135: Company 1 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 136: Company 2 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 137: Company 2 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138: Company 2 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 139: Company 3 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 140: Company 3 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141: Company 3 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 142: Company 4 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 143: Company 4 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144: Company 4 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 145: Company 5 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 146: Company 5 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147: Company 5 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 148: Company 6 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 149: Company 6 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150: Company 6 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 151: Company 7 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 152: Company 7 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153: Company 7 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 154: Company 8 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 155: Company 8 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156: Company 8 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 157: Company 9 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 158: Company 9 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159: Company 9 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 160: Company 10 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 161: Company 10 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162: Company 10 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 163: Company 11 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 164: Company 11 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165: Company 11 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 166: Company 12 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 167: Company 12 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168: Company 12 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 169: Company 13 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 170: Company 13 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171: Company 13 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 172: Company 14 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 173: Company 14 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174: Company 14 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 175: Company 15 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 176: Company 15 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 177: Company 15 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)